These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The multifaceted role of protein kinase CK2 in high-risk acute lymphoblastic leukemia. Zhou Y; Lian H; Shen N; Korm S; Kwok Ping Lam A; Layton O; Huiting LN; Li D; Miao K; Zeng A; Landesman-Bollag E; Seldin DC; Fu H; Hong L; Feng H Haematologica; 2021 May; 106(5):1461-1465. PubMed ID: 32817283 [No Abstract] [Full Text] [Related]
25. Prognostic significance of IKZF1 alteration status in pediatric B-lineage acute lymphoblastic leukemia: a meta-analysis. Feng J; Tang Y Leuk Lymphoma; 2013 Apr; 54(4):889-91. PubMed ID: 22916957 [No Abstract] [Full Text] [Related]
26. Impact of IKZF1 deletions on IKZF1 expression and outcome in Philadelphia chromosome negative childhood BCP-ALL. Reply to "incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia". Palmi C; Lana T; Silvestri D; Savino A; Kronnie GT; Conter V; Basso G; Biondi A; Valsecchi MG; Cazzaniga G Haematologica; 2013 Dec; 98(12):e164-5. PubMed ID: 24323991 [No Abstract] [Full Text] [Related]
27. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients. Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924 [TBL] [Abstract][Full Text] [Related]
28. Casein Kinase II (CK2), Glycogen Synthase Kinase-3 (GSK-3) and Ikaros mediated regulation of leukemia. Gowda C; Soliman M; Kapadia M; Ding Y; Payne K; Dovat S Adv Biol Regul; 2017 Aug; 65():16-25. PubMed ID: 28623166 [TBL] [Abstract][Full Text] [Related]
29. Tumor suppressor IKZF1 mediates glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia. Marke R; Havinga J; Cloos J; Demkes M; Poelmans G; Yuniati L; van Ingen Schenau D; Sonneveld E; Waanders E; Pieters R; Kuiper RP; Hoogerbrugge PM; Kaspers GJ; van Leeuwen FN; Scheijen B Leukemia; 2016 Jul; 30(7):1599-603. PubMed ID: 26713593 [No Abstract] [Full Text] [Related]
30. IKZF1::CIITA, a novel fusion transcript in a case of relapsed B-cell acute lymphoblastic leukemia. Sharma P; Gupta SK; Leons GK; Bakhshi S; Gupta R; Rani L; Gajendra S; Roy A; Pushpam D Pediatr Blood Cancer; 2023 Jan; 70(1):e29872. PubMed ID: 35815811 [No Abstract] [Full Text] [Related]
31. Plant homeodomain finger protein 2 as a novel IKAROS target in acute lymphoblastic leukemia. Ge Z; Gu Y; Han Q; Sloane J; Ge Q; Gao G; Ma J; Song H; Hu J; Chen B; Dovat S; Song C Epigenomics; 2018 Jan; 10(1):59-69. PubMed ID: 28994305 [TBL] [Abstract][Full Text] [Related]
32. Transcriptional Regulation of Genes by Ikaros Tumor Suppressor in Acute Lymphoblastic Leukemia. Dhanyamraju PK; Iyer S; Smink G; Bamme Y; Bhadauria P; Payne JL; Dovat E; Klink M; Ding Y Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32085659 [TBL] [Abstract][Full Text] [Related]
33. Ikaros and GATA-1 combinatorial effect is required for silencing of human gamma-globin genes. Bottardi S; Ross J; Bourgoin V; Fotouhi-Ardakani N; Affar el B; Trudel M; Milot E Mol Cell Biol; 2009 Mar; 29(6):1526-37. PubMed ID: 19114560 [TBL] [Abstract][Full Text] [Related]
34. Co-existence of IL7R high and SH2B3 low expression distinguishes a novel high-risk acute lymphoblastic leukemia with Ikaros dysfunction. Ge Z; Gu Y; Xiao L; Han Q; Li J; Chen B; Yu J; Kawasawa YI; Payne KJ; Dovat S; Song C Oncotarget; 2016 Jul; 7(29):46014-46027. PubMed ID: 27322554 [TBL] [Abstract][Full Text] [Related]
35. Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia. Churchman ML; Qian M; Te Kronnie G; Zhang R; Yang W; Zhang H; Lana T; Tedrick P; Baskin R; Verbist K; Peters JL; Devidas M; Larsen E; Moore IM; Gu Z; Qu C; Yoshihara H; Porter SN; Pruett-Miller SM; Wu G; Raetz E; Martin PL; Bowman WP; Winick N; Mardis E; Fulton R; Stanulla M; Evans WE; Relling MV; Pui CH; Hunger SP; Loh ML; Handgretinger R; Nichols KE; Yang JJ; Mullighan CG Cancer Cell; 2018 May; 33(5):937-948.e8. PubMed ID: 29681510 [TBL] [Abstract][Full Text] [Related]
36. Notch and Ikaros: not only converging players in T cell leukemia. Bellavia D; Mecarozzi M; Campese AF; Grazioli P; Gulino A; Screpanti I Cell Cycle; 2007 Nov; 6(22):2730-4. PubMed ID: 18032925 [TBL] [Abstract][Full Text] [Related]
37. Cuplike nuclear morphology is highly associated with Li W; Cooley LD; August KJ; Richardson AI; Shao L; Ahmed AA; Farooqi MS; Zwick DL Blood; 2019 Jul; 134(3):324-329. PubMed ID: 31076445 [No Abstract] [Full Text] [Related]
38. Ikaros and tumor suppression in acute lymphoblastic leukemia. Payne KJ; Dovat S Crit Rev Oncog; 2011; 16(1-2):3-12. PubMed ID: 22150303 [TBL] [Abstract][Full Text] [Related]
39. IKAROS: a multifunctional regulator of the polymerase II transcription cycle. Bottardi S; Mavoungou L; Milot E Trends Genet; 2015 Sep; 31(9):500-8. PubMed ID: 26049627 [TBL] [Abstract][Full Text] [Related]
40. Pathogenesis and regulation of cellular proliferation in acute lymphoblastic leukemia - the role of Ikaros. Wang H; Ouyang H; Lai L; Petrovic-Dovat L; Stankov K; Bogdanovic G; Dovat S J BUON; 2014; 19(1):22-8. PubMed ID: 24659638 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]